Multiscale MD simulations of wild-type and sickle hemoglobin aggregation

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Sickle cell disease is a genetic blood disorder caused by a specific mutation in hemoglobin.
• The Glu6Val mutation leads to abnormal hemoglobin aggregation, red blood cell dysfunction, and anemia.

Purpose of the Study:

• To investigate the structural and dynamic effects of the Glu6Val mutation on hemoglobin aggregation.
• To understand the molecular mechanisms underlying sickle hemoglobin self-assembly.

Main Methods:

• Multiscale molecular dynamics simulations using atomistic and coarse-grained models.
• Analysis of hemoglobin monomer, dimer, and decamer dynamics.
• Characterization of protein-protein interactions in wild-type and sickle hemoglobin aggregates.

Main Results:

• Sickle hemoglobin aggregation is driven by combined hydrophobic and electrostatic interactions at the mutation site, forming stable aggregates.
• Wild-type hemoglobin can self-assemble, but through weaker, isolated interactions that do not form stable structures.
• The mutation creates an extended interaction surface promoting pathological aggregation.

Conclusions:

• The Glu6Val mutation significantly alters hemoglobin's self-assembly properties, promoting stable aggregation through specific intermolecular forces.
• Understanding these aggregation mechanisms is crucial for designing targeted inhibitors for sickle cell disease.
• This research provides a molecular basis for developing novel therapeutic strategies.